Who
Thomas P. Lynch
Officer
Company insider
Files Form 4 as: Officer, BillionToOne; Chief Legal Compliance Officer, Nuwellis; EVP, Chief Admin Off, GC & Sec, Orexigen Therapeutics.
In numbers
- Trades disclosed
- 92
- Buys
- 1
- Sells
- 2
- Bought
- $6,000
- Sold
- $11.7M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 1 Dec 2015
- Last trade
- 13 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Oct 2026filed 19 Oct 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Code M | $17K2,000 at $8.65 | filing |
| 13 Oct 2026filed 19 Oct 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $17K2,000 at $8.65 | filing |
| 8 Oct 2026filed 13 Oct 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Code M | $69K8,000 at $8.65 | filing |
| 8 Oct 2026filed 13 Oct 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $69K8,000 at $8.65 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Code M | $168K19,384 at $8.65 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $80K6,968 at $11.55 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $50K2,920 at $17.12 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $180K5,840 at $30.78 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Code M | $80K6,968 at $11.55 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Code M | $50K2,920 at $17.12 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $168K19,384 at $8.65 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $80K6,968 at $11.55 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $50K2,920 at $17.12 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $180K5,840 at $30.78 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Code M | $180K5,840 at $30.78 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Sold | $2.1M19,384 at $110.36 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Sold | $769K6,968 at $110.30 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Sold | $322K2,920 at $110.31 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneDiagnostics & Labs | SEC FORM 4 Sold | $644K5,840 at $110.29 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BLLN BillionToOneoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $168K19,384 at $8.65 | filing |
News
Analyzing Community Health Systems (NYSE:CYH) and Billiontoone (NASDAQ:BLLN)BLLN · tickerreport.com · 18 Oct 2026Billiontoone (NASDAQ:BLLN) Stock: Insider Oguzhan Atay Sells 5,150 SharesBLLN · themarketsdaily.com · 17 Oct 2026Insider Selling: Billiontoone (NASDAQ:BLLN) CEO Sells $313,016.22 in StockBLLN · tickerreport.com · 17 Oct 2026
0 headlines in the last 90 days name Thomas P. Lynch; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.